Literature DB >> 7526251

Early changes in volume and non-enhanced volume of acoustic neurinoma after stereotactic gamma-radiosurgery.

H Oyama1, T Kobayashi, Y Kida, T Tanaka, Y Mori, T Iwakoshi, M Niwa, O Kai, M Hirose.   

Abstract

The effectiveness of stereotactic gamma-radiosurgery for treating acoustic neurinoma was evaluated by measuring the volumes of the tumor, non-enhanced tumor, and cerebellar edema in 13 patients with acoustic neurinoma who were followed up for 9 to 15 months (median 12.7 mos) after treatment. The tumor volume and non-enhanced volume tended to reach a maximum after 6 months, and cerebellar edema volume after 9 months, then decreased gradually thereafter. Hearing loss tended to increase gradually, but involvement of the facial nerve was transient.

Entities:  

Mesh:

Year:  1994        PMID: 7526251     DOI: 10.2176/nmc.34.607

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Stereotactic radiosurgery: a meta-analysis of current therapeutic applications in neuro-oncologic disease.

Authors:  Susan C Pannullo; Justin F Fraser; Jennifer Moliterno; William Cobb; Philip E Stieg
Journal:  J Neurooncol       Date:  2010-12-09       Impact factor: 4.130

2.  Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma.

Authors:  H Nakamura; H Jokura; K Takahashi; N Boku; A Akabane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

3.  Significant temporal evolution of diffusion anisotropy for evaluating early response to radiosurgery in patients with vestibular schwannoma: findings from functional diffusion maps.

Authors:  Y-C Lin; C-C Wang; Y Y Wai; Y-L Wan; S-H Ng; Y-L Chen; H-L Liu; J-J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2009-09-24       Impact factor: 3.825

4.  Diagnostic accuracy of the constructive interference in steady state sequence alone for follow-up imaging of vestibular schwannomas.

Authors:  B Ozgen; B Oguz; A Dolgun
Journal:  AJNR Am J Neuroradiol       Date:  2009-02-04       Impact factor: 3.825

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.